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Abstract
Background: Prostate cancer and benign prostatic hyperplasia are very common diseases in older
American men, thus having a reliable treatment modality for both diseases is of great importance.
The currently used treating options, mainly surgical ones, have numerous complications, which
include the many side effects that accompany such procedures, besides the invasive nature of such
techniques. Focused ultrasound is a relatively new treating modality that is showing promising
results in treating prostate cancer and benign prostatic hyperplasia. Thus this technique is gaining
more attention in the past decade as a non-invasive method to treat both diseases.
Methods: In this paper, the design, construction and evaluation of a 1.75 dimensional ultrasound
phased array to be used for treating prostate cancer and benign prostatic hyperplasia is presented.
With this array, the position of the focus can be controlled by changing the electrical power and
phase to the individual elements for electronically focusing and steering in a three dimensional
volume. The array was designed with a maximum steering angle of ± 13.5° in the transverse
direction and a maximum depth of penetration of 11 cm, which allows the treatment of large
prostates. The transducer piezoelectric ceramic, matching layers and cable impedance have been
designed for maximum power transfer to tissue.
Results: To verify the capability of the transducer for focusing and steering, exposimetry was
performed and the results correlated well with the calculated field. Ex vivo experiments using
bovine tissue were performed with various lesion sizes and indicated the capability of the
transducer to ablate tissue using short sonications.
Conclusion:  A 1.75 dimensional array, that overcame the drawbacks associated with one-
dimensional arrays, has been designed, built and successfully tested. Design issues, such as cable and
ceramic capacitances, were taken into account when designing this array. The final prototype
overcame also the problem of generating grating lobes at unwanted locations by tapering the array
elements.
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1. Background
Treating prostate diseases such as prostate cancer and
benign prostatic hyperplasia (BPH) is of great importance.
In the United States, most of the new diagnosed prostate
cancer cases appear in men who are over the age of 55
while most of the BPH cases appear after the age of 60.
According to the National Cancer Institute, 50 percent of
men between the ages of 60 and 70, and 90 percent of
men between the ages of 70 and 90, have BPH symptoms.
Prostate cancer is a life threatening disease while BPH is a
benign growth that needs to be treated since normal urine
flow can be blocked as a result of the prostate pushing
against the urethra and the bladder (National Cancer
Institute 1999).
Existing techniques for treating such diseases include
hyperthermia, focus surgery, radiotherapy, chemotherapy
and surgery. Currently, surgical techniques are widely
used over the other modalities; that is due to the ineffi-
ciency and the unpleasant side effects those modalities
have. However surgical techniques have numerous com-
plications that appear in about one in four cases, which
include impotence, incontinence, and urinary tract infec-
tions and often require lengthy hospitalization [1,2].
Due to its noninvasiveness, focus surgery is gaining more
attention than the other modalities in the past decade [3].
With focus surgery, ultrasound or microwave devices are
used to generate a focused beam at a certain location in
the prostate, which kills the cells at that location by raising
their temperature to 60°C for about ten seconds. Atten-
tion is given more to ultrasound rather than microwave.
That is because microwave has either a shallow penetra-
tion depth (when high frequencies are used) or a lack of
the ability to generate a significant focus (when low fre-
quencies are used) [4].
With focused ultrasound (FUS), tissue is noninvasively
ablated by elevating the temperature at the focal point
above 60°C using short sonications (10–30 seconds). In
this kind of treatment, the target volume can be ablated by
focusing the ultrasound beam at a certain position, and
then steering the focus to cover the whole enlarged vol-
ume. Thus FUS can be used for prostate ablation to
remove a non-desirable growth of the prostate [5-7]. Since
the tissue volume to be ablated is larger than the geomet-
ric focus of the array, the transducer needs to be moved
repeatedly to destroy the desired volume and unnecessar-
ily extend the treatment time. Phased arrays overcome this
problem by electrically steering the focal point from one
location to another by changing the phase and power to
the individual elements of the array. Previous effective
prostate ultrasound devices include both mechanically
and electrically steered designs. Electrically steered
include a one-dimensional (1-D) 120 × 1 aperiodic, linear
array design (90 × 15 mm2) which reduced grating lobes
and could steer the focus in the radial and transverse but
not the longitudinal direction [8]. Another experimental
design was a 62 × 1, linear array (75 × 15 mm2) with a
mechanical translation that could electrically steer the
focus in the radial and transverse but not the longitudinal
direction [9]. The drawbacks behind these designs are that
they can only steer the focus in the radial and transverse
directions or require complex mechanisms to move the
focus. Improvements over 1-D arrays for the treatment of
localized prostatic cancer can be achieved. Many multi-
dimensional ultrasound phased arrays have been
designed and built for the treatment of prostate diseases;
that includes a 1.5-dimensional (1.5-D) phased array [10]
(a 1.5-D array consists of three individual linear array that
can be driven individually or connected together to form
a single linear array), a 1.75-dimensional (1.75-D) phased
array [11] (a 1.75-D array consists of many individual lin-
ear arrays that are driven separately), and a two-dimen-
sional (2-D) phased array [12]. The advantage with a
multi-dimensional phased array is that it has the capabil-
ity of focusing and steering in a 3-dimensional (3-D) rep-
resentation of the prostate without the need to physically
move the array.
Issues regarding the construction of an array used for FUS
of the prostate initially deal with the frequency and size of
the ceramic to be diced into an array. The resonant fre-
quency should be greater than 500 kHz [13] while the size
of the transducer needs to be large enough to be able to
deliver high power but small enough to be an intracavi-
tary device. Before construction, computer simulations
can be performed to determine the acoustic field. Pressure
wave and temperature simulations indicated that a
tapered array design reduced grating lobes significantly
compared to equal element size arrays. Based on the com-
puter model, a tapered array that satisfied grating lobes,
frequency, and size limitations was designed. Lead zirco-
nate titanate (PZT- 8) was chosen as the ceramic material
of the array since it has the capability of handling the high
electrical powers used in focused ultrasound. To maxi-
mize the acoustical power transmission from the elements
and improve the structural integrity of the array face, two
matching layers were designed and fabricated. Issues
regarding the cabling and electrical matching of the ele-
ments were also considered. Exposimetry of the acoustic
field from the array was performed to compare experi-
mental and calculated theoretical results. Ex vivo experi-
ments using bovine tissue were also performed to
demonstrate the feasibility of the array to ablate tissue.
This paper describes the design, construction and evalua-
tion of a 1.75-D ultrasound phased array that is capable of
focusing and steering in a 3-D volume to be used in the
treatment of BPH.BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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2. Methods
2.1 Simulations
2.1.1 Acoustic pressure field simulations
MATLAB computer simulation programs were written to
determine the number and the size of the phased array
elements in addition to determining the pressure and
temperature fields from the device. The array was mod-
eled (Figure 1) as a 1.75-D tapered array in order to have
focusing and steering capabilities in both x and z direc-
tions (x = transverse, y = longitudinal and z = radial).
Focusing in the y direction is done in a different way; the
array is divided into three identical rows, each one repre-
sents a single linear array. If the focus is required at y = 0,
the middle row should be used. A focus at y = -0.9 cm
requires driving the lower row, while a focus at y = +0.9
cm requires the operation of the upper row. Although the
degree of freedom in the y direction is not perfect, the size
of the lesion generated by a single sonication compen-
sates for that, since the focus length is about 9 mm in the
y direction. With these requirements, this array was capa-
ble of focusing and steering with a steering angle of ±
13.5° with maximum focal depth of 11 cm. The phase of
each element was determined such that signals from indi-
vidual elements were coherent at the focal point. Measur-
ing the difference in path length between each element to
the focus in comparison to the path from the center of the
array to the focus determined the element phase calcula-
tion. The phase, φ i, (degrees) of element i was given by:
Where λ  is the wavelength (m), di is the distance (m) from
the centre of element i to the focal point, dois the distance
(m) from the centre of the array to the focus and n is an
integer to keep 0 ≤  φ i ≥  360°. Huygen's principle was used
to model the pressure field as a summation of simple
sources [14] and the total acoustic pressure at any point in
the field was calculated using the discrete approximation
of the Rayleigh- Sommerfeld equation:
Where p is the total acoustic pressure in Pascals (Pa), P is
the total acoustic power emitted by the array in watts (W),
ρ  is the density of the medium (998 kg·m-3), c is the speed
of sound (m·s-1), A is the total surface area of the array
(m2), f is the resonant frequency (1.2 MHz), S is the area
of the corresponding element (m2) and α  is the attenua-
tion in soft tissue (10 Np·m-1·MHz-1).
The acoustic pressure field simulations started with a 1-D
model that was used to simulate different tapering tech-
niques to see their effect on the grating lobe values. Equal,
linear, Hanning and Hamming tapering techniques were
simulated. Improvements to the tapered array design
started with a 27 × 53 mm2 solid piezoceramic cut into a
3 × 21 pattern with 63 individual elements with lengths
(Li) of 1.68, 1.73, 1.81, 1.91, 2.02, 2.14, 2.26, 2.36, 2.43,
2.48, 2.50, 2.48, 2.43, 2.36, 2.26, 2.14, 2.02, 1.91, 1.81,
1.73, 1.68 mm for elements i = 1 through 21, respectively,
and widths (Wi) of 9.0 mm for all elements i = 1 through
3, respectively (Figure 1). The maximum possible steering
angle was calculated to be tan-1(1.2/5.0) = 13.5° with
maximal focal depth of 11 cm. Off-axis focusing and the
grating lobe level are directly related to each other since
increasing the steering angle causes a nonlinear increase
in the grating lobe level. However, the designed array
described in this paper kept a good grating lobe level
when aiming the focus at a point that was 5 mm away
from the z direction. When focusing at (0.2, 0, 5) and
(0.5, 0, 5) cm, the grating lobe level was kept around -12
dB, as can be seen in Figures 2(a) and 2(b), respectively.
2.1.2 Temperature distribution simulations
From the pressure field of the simulated array, the temper-
ature distribution in the tissue was modeled using the
Pennes' bioheat transfer equation (BHTE) [15]:
Where Ct is the specific heat of the tissue (3770 J·kg-1·°C-
1), K is the thermal conductivity (0.5 W·m-1·°C-1), T is
the temperature at time t at the point x, y, z in °C, Ta is the
arterial blood temperature (37°C), w is the perfusion in
the tissue in kg·m-3·s-1, Cb is the specific heat of the blood
(3770 J·kg-1·°C-1) and q(x, y, z) is the power deposited at
the point x, y, z. The power was calculated from the pres-
sure field of the array design while the BHTE was deter-
mined using a numerical finite difference method with
the boundary conditions set at 37°C. The total intensity at
point (x, y, z) was also calculated from the pressure field
of the simulated array and is given by [16]:
Where I(x, y, z) is the intensity at point (x, y, z) in W·m-2.
Temperature simulations were used to verify the potential
to increase the tissue temperature to about 60°C with
short sonications. Both on- and off-axis simulations were
performed to see what impact they have on grating lobe
values. The effect of off-axis focusing on the temperature
distributions becomes more evident at high steering
angles. For the case where the steering angle was set to
4.75°, i.e., focus at (5, 0, 60) mm, the temperature distri-
bution was calculated and plotted in Figures 3(a–c) as a
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Based on the simulations, a diagram of the 1.75-D 63 element (3 × 21) tapered array with total size of 27 × 53 mm2 with the  proportions of the ceramic and matching layer illustrated Figure 1
Based on the simulations, a diagram of the 1.75-D 63 element (3 × 21) tapered array with total size of 27 × 53 mm2 with the 
proportions of the ceramic and matching layer illustrated. The diced face of the ceramic was cut 100% through and each indi-
vidual element was attached to the electrical cabling using low temperature soldering material.
L1 L2 L3............................................ . L20 L21
W1
W2
W3
x
1
st matching layer
2
nd matching layer
Transducer face
Prostate
x: Transverse
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z: Radial z
yBioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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Off-axis focusing has a direct impact on the grating lobe level Figure 2
Off-axis focusing has a direct impact on the grating lobe level. Increasing the steering angle by changing the focal point position 
in the x direction increases the grating lobe level. For a focus aimed at (0.2, 0, 5) and (0.5, 0, 5) cm, a fair grating lobe level of 
about -12dB was observed, as seen in (a) and (b), respectively.
(a)
(b)BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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A temperature map (a) for a focus aimed at (5, 0, 60) mm and cross section temperatures (b) and (c) across the lines a-a and  b-b, respectively, as a function of distances x and z, respectively Figure 3
A temperature map (a) for a focus aimed at (5, 0, 60) mm and cross section temperatures (b) and (c) across the lines a-a and 
b-b, respectively, as a function of distances x and z, respectively.
(a)
(b)
(c)BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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distribution at the plane of interest, a cross section along
the line a-a and a cross section along the line b-b, respec-
tively. Those three figures show that the simulated tem-
perature at the focal point was about 54°C, while the
temperature elsewhere was kept below 41°C.
2.2 Transducer construction
The 1.75-D array described in this chapter vibrates in the
thickness mode, which means that ε 33 is the permittivity
value of interest. Although Lead zirconate-titanate (PZT-
5H) has a higher permittivity, which would lead to a
higher capacitance, it cannot handle the large power that
is used in FUS. PZT-4 and PZT-8 are good candidates con-
cerning power, with an advantage for PZT-8 over PZT-4.
The capacitance of a certain element in the array depends
on the thickness (which is constant for all elements), the
permittivity (which is a material characteristic) and the
surface area of that element. Since the areas of the ele-
ments of the array are small, this will result in a small
capacitance and thus large element impedance.
PZT-8 can handle the large electrical power needed for tis-
sue ablation, has an extremely high mechanical quality
factor and extremely low loss factor. Thus PZT-8 material
(TRS Ceramics, State College, PA, USA) was chosen at a
frequency of 1.2 MHz and diced, in house, into 3 × 21 ele-
ments forming the complete array. The cuts were made by
dicing the material 100% through its thickness with a kerf
width of 300 µm using a dicing saw (Model 780, K & S-
Kulick and Soffa Industries, Willow Grove, PA, USA) in
our lab. For maximum acoustical power transfer from the
individual elements to the tissue, two matching layers
were designed and constructed. The thickness and mate-
rial selection of the matching layers were designed based
on the solution to a four-layer problem (transducer, first
matching layer, second matching layer, and tissue), which
ensured the required maximum power transfer. The
acoustic impedance of the two matching layers (Z1 and
Z2) was calculated using a criterion determined by Fraser:
Z1 = (Zpiezo)4/7 (Ztissue)3/7   (5)
Z2 = (Zpiezo)1/7 (Ztissue)6/7   (6)
Each of the two matching layers was designed for a quarter
wavelength thickness. Accordingly, the thickness of the
first and second matching layers was determined to be
0.396 and 0.429 mm, respectively. The first matching
layer, mixed in-housed, was a 2:1, epoxy to silver mixture
of Insulcast 501 (Insulcast, Roseland, NJ, USA) and 2–3
micron silver epoxy (Aldrich, Milwaukee, WI, USA), while
the second matching layer was a SPURR (Spi Supplies,
West Chester, PA, USA) four-part low viscosity material.
For this array design (Figure 4), the specially machined,
waterproof cylindrical applicator housing (30 mm diam-
eter) was made from magnet compatible Delrin®
(Dupont, Wilmington, DE, USA) at the Penn State engi-
neering shop.
Transmission line theory applies to the coaxial cables used
in ultrasound applications. The simplest approximation
for the transmission line is a lumped capacitance, where
the total cable capacitance can be measured by multiply-
ing the cable capacitance per meter, Cm, by the length of
the cable L in meters. Since the load impedance (element
impedance) is high, the cable has to be a low capacitance
cable, which effectively means high cable impedance. A
cable with a characteristic impedance of 75 Ω  was found
to be suitable
The 1.75-D array contains 63 elements. Since those ele-
ments are of different size, each one of them will have dif-
ferent electrical impedance depending on the surface area
of that element which determines the capacitance of that
element and thus the electrical impedance. The target is to
match each one of these impedances to the common
value of 50Ω∠ 0°. A simple LC (L = inductor, C = capaci-
tor) impedance matching circuit was built for each of the
63 elements.
Photograph of the constructed, waterproof array with 7.0 m  low capacitance cable that connected to the amplifier system Figure 4
Photograph of the constructed, waterproof array with 7.0 m 
low capacitance cable that connected to the amplifier system.BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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2.3 Exposimetry
To determine the acoustic field generated by the array, an
automated computer controlled positioning system,
which could translate a hydrophone (needle one with 0.5
mm diameter, Precision Acoustics, UK) throughout the
acoustic field of the array placed in a water tank, was used.
The transducer was submerged in water (room tempera-
ture, approximately 20°C) in a tank (120 × 50 × 52 cm3)
made almost anechoic with sound absorbing rubber. A
custom made degasser, built in-house, was used to reduce
the dissolved oxygen content of the distilled water to 1–2
ppm to reduce cavitation. The system was controlled
using a personal computer connected to a four-motor
positioning system (Velmex Inc., Bloomfield, NY, USA)
via the RS232 serial port and also connected, via the gen-
eral purpose interface bus (GPIB), to a digital oscilloscope
(Agilent 54622A, Agilent Technologies, Palo Alto, CA,
USA) which recorded the voltage amplitudes detected by
the hydrophone. Custom written, Quick Basic (Microsoft
Corporation, Redmond, WA, USA) programs were used
for automated control of the motors and data acquisition
from the oscilloscope. Initially, multiple on-axis (i.e.
where the focus is along the major z axis, zf) exposimetry
experiments were performed. With the focus set to 0, 0, zf
mm, zf was varied from 10 mm to 110 mm with a step size
of 5 mm. To determine the repeatability or standard devi-
ation of the focusing, 5–10 experiments were performed
at each location. For off-axis studies (i.e., where the focus
was not on z but aimed toward the x axis, xf), the focus
was located at (xf, 0, 60) mm while the steering angle was
adjusted to the desired value by choosing appropriate val-
ues for xf. The steering angle was varied from -12° to +12°
with a step size of 2° in both x and y directions with mul-
tiple experiments (5–10) performed at each angle. In both
the on-axis and off-axis experiments, the scanning step
size was 0.5 mm while the scanning area was 40 × 40
mm2. The hydrophone voltage recordings were used to
calculate the normalized intensities based on the pres-
sures that were plotted as the mean and standard devia-
tion of the results (x ± s.d.) and compared against the
calculated values.
2.4 Ex vivo experiments
To test the ability of the array to generate lesions in non-
perfused bovine tissue, the array was submerged 6 cm in
water and aimed perpendicular to the surface of water.
Fresh bovine tissue was obtained, placed in the water tank
and held 2.5 cm in front of the array. For both on- and off-
axis focusing, a single linear array was driven with an aver-
age electrical power of 1 Watt per element for six to seven
minutes.
3. Results
To compare experimental and theoretical results, more
than fifty exposimetry experiments were performed
throughout the desired ablation volume to determine the
focusing capability of the array. As an example of a typical
exposimetry result at the location (x, y, z) = (0, 0, 40) mm,
Figure 5(a) shows a comparison plot along the z-axis of
the calculated and experimental normalized intensities.
Figure 5(b) plots similar theoretical and experimental
data but instead along the x-axis for the same focus (0, 0,
40 mm). As can be seen for both plots, the theoretical
intensity data correlated well with the experimental
results. To evaluate the feasibility of the array to steer the
focus, a typical three dimensional normalized intensity
result from a focal point directed at 0, 0, 40 mm. The
results were plotted as a mesh (Figure 6(a)) and contour
(Figure 6(b)) with contour levels at 0, -1, -2, -3, -6 and -9
dB of the normalized intensity with the grating lobe levels
at about -9.0 dB or less.
Ex vivo experiments were also performed to verify the abil-
ity of the array to generate lesions in bovine tissue. In one
experiment, the array was turned on for about six minutes.
After turning the array off, the bovine piece was cut at the
position where the focal point was aimed. A lesion that
has the dimensions of 1 cm × 0.3 cm was observed, as Fig-
ure 7(a) shows. An unmarked version of Figure 7(a) is
shown in Figure 7(b) for better visualization of the lesion.
During the experiment, thermocouples were used to mon-
itor the temperature at two locations, the focal point and
the grating lobe locations. The temperature recording, Fig-
ure 7(c), shows that the focal point temperature reached
about 52°C, while the grating lobe temperature was kept
below 40°C, as compared to the simulated values (using
the BHTE) of 51.7°C and 40.2°C, respectively. In another
experiment, the array was turned on for about seven min-
utes and then turned off. The observed lesion was approx-
imately 1.3 cm × 0.38 cm in size, as shows in the marked
picture of the lesion, Figure 8(a). The same picture, but
without marking the lesion, is shown in Figure 8(b) for
better visualization of the lesion. The temperature record-
ings for this experiment show that the temperature at the
focal point position increased to reach about 49.5°C
while the temperature at the grating lobe position was
about 39°C at the end of the experiment, as shown in Fig-
ure 8(c). Although the sonication time for this experiment
was seven minutes while it was six minutes for the exper-
iment shown in Figure 8, the final temperature value at
the focal point was less for the seven minute experiment
as compared to the six minute one. This might be due to
the uncertainty of the location of the thermocouples.
4. Discussion
Intracavitary ultrasound offers an attractive means of
focused ultrasound treatment for BPH with significant
advantages over other treatment methods due to the rela-
tively short treatment time, its noninvasive nature and
reduced complications. One compelling reason for usingBioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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Comparison of calculated and experimental normalized intensities for a focus at 0, 0, 40 mm plotted along the (a) z axis and (b)  x axis Figure 5
Comparison of calculated and experimental normalized intensities for a focus at 0, 0, 40 mm plotted along the (a) z axis and (b) 
x axis.
(a)
(b)BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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Exposimetry results of the normalized intensity for off-axis focusing with the focal point aimed at 0, 0, 40 mm plotted as a (a)  mesh or (b) contour with levels indicated at 0, -1, -2, -3, -6 and -9 dB Figure 6
Exposimetry results of the normalized intensity for off-axis focusing with the focal point aimed at 0, 0, 40 mm plotted as a (a) 
mesh or (b) contour with levels indicated at 0, -1, -2, -3, -6 and -9 dB. These results indicate acceptable grating lobes of less 
than -9 dB.
(a)
(b)BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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(a) A lesion, with dimensions of about 1 cm × 0.3 cm, generated by a six minute sonication time experiment (b) Temperature  recordings at the locations of the focal point and grating lobe Figure 7
(a) A lesion, with dimensions of about 1 cm × 0.3 cm, generated by a six minute sonication time experiment (b) Temperature 
recordings at the locations of the focal point and grating lobe.
(a)
(b)
(c)BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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A marked (a) and unmarked (b) lesion, with dimensions of 1.3 cm × 0.38 cm, generated by a seven minute sonication time  experiment, and the temperature recordings (c) at the locations of the focal point and grating lobe Figure 8
A marked (a) and unmarked (b) lesion, with dimensions of 1.3 cm × 0.38 cm, generated by a seven minute sonication time 
experiment, and the temperature recordings (c) at the locations of the focal point and grating lobe.
(a)
(b)
(c)BioMedical Engineering OnLine 2005, 4:39 http://www.biomedical-engineering-online.com/content/4/1/39
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an intracavitary device with focused ultrasound is that the
prostate is easily accessible via transrectal applicators,
which allow for heating of the target volume in the pros-
tate with minimal heating of normal tissue. Using phased
arrays to electrically focus the ultrasound beam provides a
controlled localized power deposition into tissue and
reduces significantly the treatment time since the focus is
electronically scanned instead of manually.
In designing this array, several issues were taken into
account to address its application for BPH treatment. The
dimensions of array were designed for an intracavitary rec-
tal device. With appropriate housing, the array dimen-
sions of 2.7 × 5.3 cm2  are suitable. Another issue
concerning this design was the grating lobe level, which
was reduced significantly by tapering the array element
lengths.
To treat the prostate, the array was aimed toward the
intended target volume, and the elements were driven at a
calculated amplitude and phase to generate a single focal
point with electrical steering.
The array can ablate a volume that lies in its steering vol-
umes. Assuming that the volume to be ablated is 1 × 1 × 2
cm3 and that its center is 3 cm away from the array face,
two techniques can be used as a treatment plan to ablate
the whole volume; the first one is using a single focal
point regime in which the target volume is divided into
small volumes. The size of these small volumes is chosen
based on the size of the lesion and the sonication time.
Assuming that the lesion was a 4 mm long cigar shape
with 2 mm diameter for a 10 second sonication, dividing
the 1 × 1 × 2 cm3 volume into 5 × 5 × 5 points indicates
that 125 sonications are needed to ablate the target based
on a single 10 second sonication that is electronically
steered between the 125 positions. Starting at the center of
the target volume, a single focal point is generated there
and then electronically steered 125 times to cover the
whole volume. To avoid uncontrolled heat buildup and
pre-focal heating, the switching between the focal points
is done in a way that any two focal points consecutive in
time are far away from each other in distance. By doing
that, enough time is given to the pre-focal positions to
cool down. A second technique to ablate a large volume is
by generating multi-focal points at the same time. Divid-
ing the array into three areas, each responsible for gener-
ating a single focal point, will result in reducing the
overall treatment time by a factor of three. This technique
is time efficient, but the drawback behind it is that the
driving electrical power per unit area should be increased.
If the maximum possible steering angle is 13.5° in the
transverse direction, as the case for this array design,
attempting to focus outside this volume will add a signif-
icant amount of energy to the grating lobes which will
cause an unwanted heating. This puts a limitation for the
array if the target volume extends beyond the 13.5° limit.
When coupled with MR temperature mapping, FUS pro-
vides an efficient way to treat BPH and at the same time
gives a quick feedback about the temperature distribution
inside the prostate [8]. Although ultrasound imaging for
the prostate has shown to give good results [5,17], the
array described here was designed to accompany an MRI.
Similar to prostate cancer treatment with focused ultra-
sound, benign fibroadenomas in the breast are currently
treated clinically using multiple sonications from a single
element transducer, which is mechanically scanned [18],
in conjunction with MRI for guidance of thermotherapy
of the procedure [19]. Although the treatment has been
shown to be effective, the process includes an unnecessary
delay due to the mechanical scanning protocol. When
closely spaced locations are targeted with focused ultra-
sound, thermal buildup results from the accumulation of
neighboring sonications and the nearfield heating. As a
result, a lengthy delay between sonications (cooling time)
is required to reduce thermal buildup. Investigators have
shown that a cooling time of 50–60 seconds was neces-
sary to reduce the heat from the near neighbor sonications
[20] however this can add considerable time to the proce-
dure and initiate inaccuracies to the MR thermometry
through patient motion. With phased arrays a focal pat-
tern can be arranged such that there is enough time for the
heat to dissipate by sonicating non-neighboring regions
within the tumor [21]. A treatment planning routine can
be plotted over the entire tumor region such that the vol-
ume is ablated through distant and non-adjacent abla-
tions to avoid thermal buildup yet destroy the volume in
the least amount of time. This research demonstrates the
feasibility of electrically steered arrays that can be used to
ablate tissue for the intended treatment of benign pros-
tatic hyperplasia.
5. Conclusion
A 1.75-D ultrasound phased array, that can focus and steer
in a 3-D representation of the prostate without the need to
physically move the array, had been successfully built and
tested for the treatment of prostate cancer and BPH. Previ-
ous focused ultrasound array designs were problematic
since they required complex methods to move the focus,
as for the case of annular arrays, or had linear (1-D)
designs that were only capable of focusing along one axis.
These drawbacks were the motivation to design a new
array that can be used in FUS and at the same time be sys-
tematically controlled to reposition the focus throughout
a specific volume with an acceptable level of grating lobes.
Further improvement over this array design seems to be
feasible due to recent developments in building focusedPublish with BioMed Central    and   every 
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transducers using piezocomposite technology [22]. A
three-layer PZT-8 material may also be used to increase
the capacitance and thus make it easier to electrically
match the small elements.
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